Testosterone enanthate is used mainly in androgen replacement therapy. It is the most widely used form of testosterone in androgen replacement therapy. The medication is specifically approved, in the United States, for the treatment of hypogonadism in men, delayed puberty in boys, and breast cancer in women. It is grouped under the following drug class(es): Androgens, Hormones and Steroids. Its therapeutic use is listed as sexual dysfunction agents. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Delatestryl, Androtardyl, Testosterone heptanoate and Atlatest. It is listed as a controlled drug substance (Schedule III). Its PubChem CID is 9416.
Testosterone enanthate
| CAS No | 315-37-7 |
|---|---|
| Molecular Formula | C26H40O3 |
| Molecular Weight | 400.6 g/mol |
| Synonyms | [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Testosterone enanthate is used mainly in androgen replacement therapy. It is the most widely used form of testosterone in androgen replacement therapy. The medication is specifically approved, in the United States, for the treatment of hypogonadism in men, delayed puberty in boys, and breast cancer in women.
The listed CAS number is 315-37-7.
The listed molecular formula is C26H40O3.
The listed molecular weight is 400.6 g/mol.
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate.
The source lists Delatestryl, Androtardyl, Testosterone heptanoate and Atlatest.